Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Thrombocytopenia: early-phase trial registry
6 of 23 indexed Thrombocytopenia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #724 of 28,707 conditions by registered trial count.
23 US clinical trials · 6 currently recruiting · #724 of 28,707 conditions by registered trial count
Thrombocytopenia: 23 US clinical trials tracked, 6 recruiting.
Thrombocytopenia is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 3 of these trials.
Enrollment posture brief
Registry condition thrombocytopenia
OPEN 6 | RECR 26% | LATE 1 | EARLY 15 | RANK #724 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Parkinson's Disease (26% recruiting · 161 trials)
Thrombocytopenia lists 6 open slots (26% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Thrombocytopenia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Thrombocytopenia is recruiting below its size-band peers.
6 of 23 indexed trials (26.1%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Thrombocytopenia trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 3 of 23 trials (13%). 21 distinct sponsors appear on at least one study for this condition label.
-
Most Thrombocytopenia trials plan to enrol fewer than 100 people.
Median target enrolment is 48 among the 21 trials that report a genuine target (sentinel values excluded). 16 of those (76.2%) plan for fewer than 100 participants.
-
Thrombocytopenia research is mostly interventional.
22 interventional and 1 observational studies make up this index (95.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
23 total, page 1 of 1
Neonatal Platelet Transfusion Threshold Trial
NICHD Neonatal Research Network
NCT06676904
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
University of Colorado, Denver
NCT06349577
Platelet-Directed Whole Blood Transfusion Strategy for Malaria
Johns Hopkins Bloomberg School of Public Health
NCT05711485
Luspatercept for Clonal Cytopenias of Uncertain Significance
Weill Medical College of Cornell University
NCT06788691
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
NCT07025512
Apixaban in Thrombocytopenia
Rushad Patell
NCT06886516
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
Memorial Sloan Kettering Cancer Center
NCT04673266
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
University of Utah
NCT05634005
Effects of a Platelet Transfusion Best Practices Alert
Stanford University
NCT04155775
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
GlaxoSmithKline
NCT00110799
Eltrombopag for Post Transplant Thrombocytopenia
M.D. Anderson Cancer Center
NCT01000051
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Amgen
NCT00413283
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
SWOG Cancer Research Network
NCT00002665
A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects
Eisai
NCT02039076
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
University of California, San Francisco
NCT00305708
Daclizumab to Treat Chronic Immune Thrombocytopenia
National Institutes of Health Clinical Center (CC)
NCT00049725
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
Encysive Pharmaceuticals
NCT00039858
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
M.D. Anderson Cancer Center
NCT01428635
Thrombopoietin Levels and Platelet Transfusion in Neonates
Christiana Care Health Services
NCT00549484
TPO-Mimetic Use in Children for Hematopoietic Failure
Anjali Sharathkumar
NCT04478227
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI)
NCT02298933
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
Drexel University College of Medicine
NCT00003619
Stem Cell Transplantation (SCT) for Genetic Diseases
National Center for Research Resources (NCRR)
NCT00004378
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 10 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Thrombocytopenia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Thrombocytopenia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Thrombocytopenia page
23 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Thrombocytopenia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Thrombocytopenia trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Thrombocytopenia condition card totals 23 registered trials; most-linked intervention busulfan; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.